The DOI matches its Crossref record.
Studies on the catabolism of N G-methylarginine, N G, N G-dimethylarginine and N G, N G-dimethylarginine in the rabbit
Open accessAbstract
1. The routes of elimination of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine were investigated in the rabbit. 2. Analyses showed low plasma concentrations of these amino acids (around 1 nmol/ml) and ratios similar to those found in tissue proteins. The concentrations of these amino acids in extracts of brain, kidney, liver and spleen were similar except that liver had a lower concentration of Ng-methylarginine and Ng, Ng-dimethylarginine. Cerebrospinal fluid contained traces of each amino acid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Endogenous Nitric Oxide Synthase Inhibitor: A Novel Marker of Atherosclerosis
Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756
Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Tsao, P. S., Her, J.-H., Kimoto, M., Balint, R. F., & Cooke, J. P. (2001) · Circulation · doi:10.1161/hc4601.098514 · Cited by 662
Lin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000027109.14149.67 · Cited by 651
Achan, V., Broadhead, M., Malaki, M., Whitley, G., Leiper, J., MacAllister, R., & Vallance, P. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593
Does ADMA Cause Endothelial Dysfunction?
Cooke, J. P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2032 · Cited by 581
Vallance, P., & Leiper, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000128897.54893.26 · Cited by 553
Böger, R. H., Bode-Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490
Böger, R. H., Sydow, K., Borlak, J., Thum, T., Lenzen, H., Schubert, B., Tsikas, D., & Bode-Böger, S. M. (2000) · Circulation Research · doi:10.1161/01.res.87.2.99 · Cited by 479
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
Sibal, L., C Agarwal, S., D Home, P., & H Boger, R. (2010) · Current Cardiology Reviews · doi:10.2174/157340310791162659 · Cited by 433
Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis
Chan, J., Tanaka, K., Carroll, D., Flynn, J., & Bloom, B. R. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.736-740.1995 · Cited by 407
Asymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
BOGER, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00500-5 · Cited by 393
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function–a meta-analysis
Kielstein, J. T., Salpeter, S. R., Bode-Boeger, S. M., Cooke, J. P., & Fliser, D. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl292 · Cited by 363
KIELSTEIN, J. T., BÖGER, R. H., BODE-BÖGER, S. M., SCHÄFFER, J., BARBEY, M., KOCH, K. M., & FRÖLICH, J. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103594 · Cited by 361
Ogawa, T., Kimoto, M., & Sasaoka, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81786-0 · Cited by 360
Cellular ADMA: Regulation and action
Teerlink, T., Luo, Z., Palm, F., & Wilcox, C. S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.08.002 · Cited by 342
Tran, C. T. L., Leiper, J. M., & Vallance, P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00032-1 · Cited by 314
Böger, R. H., Bode-Böger, S. M., Sydow, K., Heistad, D. D., & Lentz, S. R. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1557 · Cited by 278
Fujiwara, N., Osanai, T., Kamada, T., Katoh, T., Takahashi, K., & Okumura, K. (2000) · Circulation · doi:10.1161/01.cir.101.8.856 · Cited by 242
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Wilcock, D. M., & Griffin, W. S. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-84 · Cited by 230
“Aβ: β-amyloid; AD: Alzheimer's disease; ADMA: Asymmetric dimethylarginine; ALS: Anterolateral sclerosis; APP: Precursor protein of β-amyloid; APP: Precursor protein; BACE2: β-amyloid cleavage enzyme 2; CBS: Cystathionine beta synthase; CNS: Central nervous system; DS: Down’s syndrome; DSCR: Down’s syndrome critical re…”
BackgroundInfluentialNeuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
Wilcock, D. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/170276 · Cited by 104
Ueda, S., Yamagishi, S.-I., Matsumoto, Y., Fukami, K., & Okuda, S. (2007) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0471-x · Cited by 65
Böger, R. H., Maas, R., Schulze, F., & Schwedhelm, E. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.196 · Cited by 65
Cakir, E., Ozcan, O., Yaman, H., Akgul, E. O., Bilgi, C., Erbil, M. K., & Yesilova, Z. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2045 · Cited by 28
Metadata
- Authors
- McDermott, J. R.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1976-01-15
- Volume
- 154
- Issue
- 1
- Pages
- 179-184
- ISSN
- 0264-6021 (ISSN-L)
- OpenAlex
- W2415194500
- Cited by
- 192
- References
- 0
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.